Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Go back to Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza| Assisted Living Concepts, Inc. New (NYSE: ALC) | Delayed: 63.76 -0.18 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.94 | 52 Week High | $14.66 | |||
| Open | $64.39 | 52 Week Low | $6.93 | |||
| Day High | $64.42 | P/E | N/A | |||
| Day Low | $63.50 | EPS | $-1.75 | |||
| Volume | 1,274,346 | |||||
| Assisted Living Concepts, Inc. New (NYSE: ALC) | Delayed: 63.76 -0.18 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.94 | 52 Week High | $14.66 | |||
| Open | $64.39 | 52 Week Low | $6.93 | |||
| Day High | $64.42 | P/E | N/A | |||
| Day Low | $63.50 | EPS | $-1.75 | |||
| Volume | 1,274,346 | |||||

